No black box warning on record for Timolol Maleate Ophthalmic Gel Forming Solution 0.25%

As of the latest FDA labeling reviewed, Timolol Maleate Ophthalmic Gel Forming Solution 0.25% (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25%) does not carry a black box warning. Standard warnings and precautions still apply — see the full Timolol Maleate Ophthalmic Gel Forming Solution 0.25% medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS As with many topically applied ophthalmic drugs, this drug is absorbed systemically. The same adverse reactions found with systemic administration of beta adrenergic blocking agents may occur with topical ophtalmic administration. For example, severe respiratory reactions and cardiac reactions, including death due to bronchospasm in patient with asthma, and rarely death in association wit

No black box warning on record for Timolol Maleate Ophthalmic Gel Forming Solution 0.25%

Other warnings & precautions

WARNINGS As with many topically applied ophthalmic drugs, this drug is absorbed systemically. The same adverse reactions found with systemic administration of beta adrenergic blocking agents may occur with topical ophtalmic administration. For example, severe respiratory reactions and cardiac reactions, including death due to bronchospasm in patient with asthma, and rarely death in association wit

Timolol Maleate Ophthalmic Gel Forming Solution 0.25% Black Box Warning

No black box warning on record for Timolol Maleate Ophthalmic Gel Forming Solution 0.25%

Other warnings & precautions

Timolol Maleate Ophthalmic Gel Forming Solution 0.25% Black Box Warning

No black box warning on record for Timolol Maleate Ophthalmic Gel Forming Solution 0.25%

Other warnings & precautions